Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab

Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis

NCT01313221 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00710580 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments

NCT00967538 ·Status: COMPLETED ·Phase: PHASE4

Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00691964 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo.

NCT01900782 ·Status: WITHDRAWN ·Phase: PHASE3

Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet

NCT00585650 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390g

NCT00109252 ·Status: COMPLETED ·Phase: PHASE3

A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.

NCT02425826 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis

NCT01358578 ·Status: COMPLETED ·Phase: PHASE3

Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis

NCT00800982 ·Status: COMPLETED ·Phase: NA

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

NCT02201524 ·Status: TERMINATED ·Phase: PHASE2

AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis

NCT01132612 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis

NCT03358290 ·Status: TERMINATED ·Phase: PHASE2

Acitretin and Etanercept in Psoriasis

NCT00156247 ·Status: COMPLETED ·Phase: PHASE2

Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate

NCT02313922 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate Raptiva in Subjects With Chronic Moderate or Worse Plaque Psoriasis Who Have Had an Inadequate Response to an Anti-TNF Agent

NCT00336973 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients

NCT04398732 ·Status: COMPLETED

Study of Etanercept in the Treatment of Psoriasis in Adult Subjects

NCT00121615 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)

NCT02346240 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet

NCT00312026 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00195676 ·Status: COMPLETED ·Phase: PHASE3

Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis

NCT00111449 ·Status: COMPLETED ·Phase: PHASE3

GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis

NCT03202004 ·Status: WITHDRAWN ·Phase: PHASE3

Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis

NCT00832364 ·Status: WITHDRAWN ·Phase: PHASE4

Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis

NCT00227240 ·Status: COMPLETED